197 related articles for article (PubMed ID: 37379350)
1. Impact of a bi-annual community-directed treatment with ivermectin programme on the incidence of epilepsy in an onchocerciasis-endemic area of Mahenge, Tanzania: A population-based prospective study.
Bhwana D; Amaral LJ; Mhina A; Hayuma PM; Francis F; Siewe Fodjo JN; Mmbando BP; Colebunders R
PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011178. PubMed ID: 37379350
[TBL] [Abstract][Full Text] [Related]
2. The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol.
Abd-Elfarag G; Logora MY; Carter JY; Ojok M; Songok J; Menon S; Wit F; Lako R; Colebunders R
Infect Dis Poverty; 2018 Nov; 7(1):112. PubMed ID: 30424817
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin.
Mmbando BP; Suykerbuyk P; Mnacho M; Kakorozya A; Matuja W; Hendy A; Greter H; Makunde WH; Colebunders R
Infect Dis Poverty; 2018 Jun; 7(1):64. PubMed ID: 29921319
[TBL] [Abstract][Full Text] [Related]
4. Evolution of epilepsy prevalence and incidence in a Tanzanian area endemic for onchocerciasis and the potential impact of community-directed treatment with ivermectin: a cross-sectional study and comparison over 28 years.
Greter H; Mmbando B; Makunde W; Mnacho M; Matuja W; Kakorozya A; Suykerbuyk P; Colebunders R
BMJ Open; 2018 Mar; 8(3):e017188. PubMed ID: 29605818
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures.
Gumisiriza N; Mubiru F; Siewe Fodjo JN; Mbonye Kayitale M; Hotterbeekx A; Idro R; Makumbi I; Lakwo T; Opar B; Kaducu J; Wamala JF; Colebunders R
Infect Dis Poverty; 2020 Mar; 9(1):12. PubMed ID: 32114979
[TBL] [Abstract][Full Text] [Related]
6. Impact of annual community-directed treatment with ivermectin on the incidence of epilepsy in Mvolo, a two-year prospective study.
Amaral LJ; Jada SR; Ndjanfa AK; Carter JY; Abd-Elfarag G; Okaro S; Logora MY; Bol YY; Lakwo T; Fodjo JNS; Colebunders R
PLoS Negl Trop Dis; 2024 Mar; 18(3):e0012059. PubMed ID: 38512994
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin.
Siewe Fodjo JN; Tatah G; Tabah EN; Ngarka L; Nfor LN; Chokote SE; Mengnjo MK; Dema F; Sitouok AT; Nkoro G; Ntone FE; Bissek AZ; Chesnais CB; Boussinesq M; Colebunders R; Njamnshi AK
Infect Dis Poverty; 2018 Dec; 7(1):114. PubMed ID: 30501640
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment.
Mukendi D; Tepage F; Akonda I; Siewe JNF; Rotsaert A; Ndibmun CN; Laudisoit A; Couvreur S; Kabutako B; Menon S; Hotterbeekx A; Colebunders R
Int J Infect Dis; 2019 Feb; 79():187-194. PubMed ID: 30711145
[TBL] [Abstract][Full Text] [Related]
9. Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria.
Siewe JNF; Ukaga CN; Nwazor EO; Nwoke MO; Nwokeji MC; Onuoha BC; Nwanjor SO; Okeke J; Osahor K; Chimechefulam L; Ogomaka AI; Amaechi AA; Ezenwa CI; Ezike MN; Ikpeama C; Nwachukwu O; Eriama-Joseph AI; Nwoke BEB; Colebunders R
Infect Dis Poverty; 2019 Jan; 8(1):8. PubMed ID: 30670093
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of epilepsy and relationship with onchocerciasis prevalence in villages of the Ntui Health District of Cameroon.
Ngarka L; Siewe Fodjo JN; Ambomatei C; Njamnshi WY; Taryunyu Njamnshi JN; Nfor LN; Mengnjo MK; Njamnshi AK
Epilepsy Behav; 2023 May; 142():109184. PubMed ID: 36972641
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan: A community-based survey.
Colebunders R; Y Carter J; Olore PC; Puok K; Bhattacharyya S; Menon S; Abd-Elfarag G; Ojok M; Ensoy-Musoro C; Lako R; Logora MY
Seizure; 2018 Dec; 63():93-101. PubMed ID: 30468964
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation of epilepsy in six villages in an onchocerciasis endemic area in Mahenge, Tanzania.
Bhwana D; Mmbando BP; Dekker MC; Mnacho M; Kakorozya A; Matuja W; Makunde WH; Weckhuysen S; Colebunders R
Epileptic Disord; 2019 Oct; 21(5):425-435. PubMed ID: 31649005
[TBL] [Abstract][Full Text] [Related]
13. Effect of onchocerciasis elimination measures on the incidence of epilepsy in Maridi, South Sudan: a 3-year longitudinal, prospective, population-based study.
Jada SR; Amaral LJ; Lakwo T; Carter JY; Rovarini J; Bol YY; Logora MY; Hadermann A; Hopkins A; Fodjo JNS; Colebunders R
Lancet Glob Health; 2023 Aug; 11(8):e1260-e1268. PubMed ID: 37474232
[TBL] [Abstract][Full Text] [Related]
14. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
[TBL] [Abstract][Full Text] [Related]
15. Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon.
Boullé C; Njamnshi AK; Dema F; Mengnjo MK; Siewe Fodjo JN; Bissek AZ; Suykerbuyk P; Lenou-Nanga CG; Nana-Djeunga HC; Kamgno J; Chesnais CB; Boussinesq M; Colebunders R
Parasit Vectors; 2019 Mar; 12(1):114. PubMed ID: 30890155
[TBL] [Abstract][Full Text] [Related]
16. Untreated villages and factors associated with the absence of Community-Directed Treatment with Ivermectin (CDTI) in DRC.
Makenga Bof JC; Ntumba Tshitoka F; Mpunga Mukendi D; Mansiangi Mankadi P; Ilunga-Ilunga F; Coppieters Y
J Infect Dev Ctries; 2018 Sep; 12(9):771-779. PubMed ID: 31999636
[TBL] [Abstract][Full Text] [Related]
17. Ivermectin treatment response in two rural villages with a high prevalence of onchocerciasis and epilepsy, Mahenge Tanzania.
Bhwana D; Mmbando BP; Dusabimana A; Mhina A; Challe DP; Fodjo JNS; Makunde WH; Colebunders R
Afr Health Sci; 2022 Sep; 22(3):607-616. PubMed ID: 36910370
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo.
Levick B; Laudisoit A; Tepage F; Ensoy-Musoro C; Mandro M; Bonareri Osoro C; Suykerbuyk P; Kashama JM; Komba M; Tagoto A; Falay D; Begon M; Colebunders R
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005732. PubMed ID: 28708828
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of onchocerciasis control in the Upper Denkyira East municipal in the forest area of Ghana: Responses of participants and distributors to the CDTI programme.
Agyemang ANO; Badu K; Baffour-Awuah S; Owusu-Dabo E; Biritwum NK; Garms R; Kruppa TF
Acta Trop; 2018 Sep; 185():357-362. PubMed ID: 29932933
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting community participation in the CDTI program in Morogoro, Tanzania.
York KJ; Kabole I; Mrisho M; Berry DM; Schmidt E
J Nurs Scholarsh; 2015 Jan; 47(1):96-104. PubMed ID: 25565278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
